METHODS	This is a prospective , randomized , fellow-eye controlled clinical trial conducted on 60 eyes of 30 patients ( mean age 52.3 7.8 years ; 57 % male ) with early - to high-risk proliferative diabetic retinopathy type II diabetes who received standard red or green laser treatment .\